Month: May 2026

European EHR/EPR Market Enters Research-Ready Era as Clinical Trials and Real-World Evidence Move Into the Hospital Data Environment

Q1-Q2 2026 European provider-user Black Book Research survey finds data valorisation, governed secondary use, cohort discovery, trial feasibility and RWE...

Black Book HIMSS26 Europe Pulse: Hospital Buyers Say Digital Care Continuity, Not AI Hype, Is the Underreported Investment Priority

New survey of HIMSS26 Europe attendees finds patient-flow visibility, cyber recoverability, workflow reliability, interoperability and operational command capability are now...

Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders’ Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway

Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury

U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans...

Fate Therapeutics Announces Presentations at 2026 ASCO and EULAR Annual Meetings Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases

SAN DIEGO, May 21, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing...

NewGenIVF Announces Strategic Investment Agreement with Tech Veteran Andy Cheung-Led K25.ai, an AI-Powered Live-Streaming Prediction Market, at US$100 Million Valuation

Initial US$2 million strategic investment values K25.ai at US$100 million pre-money, with option to invest up to US$10 million if...

error: Content is protected !!